Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb/III Parallel-arm, Random., Active-controlled, Double-blind, Double-dummy, Multicenter, Non-inferiority Study in Patients With RVVC to Compare Efficacy, Safety and Tolerability of Topically Administered ProF-001 to Oral Fluconazole

NCT04734405 is registered in ClinicalTrials.gov with ProFem GmbH as lead sponsor.

NCT NCT04734405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04734405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb/III Parallel-arm, Random., Active-controlled, Double-blind, Double-dummy, Multicenter, Non-inferiority Study in Patients With RVVC to Compare Efficacy, Safety and Tolerability of Topically Administered ProF-001 to Oral Fluconazole
Lead sponsor
ProFem GmbH
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 1, 2019
Completion date
December 30, 2022
Enrollment
432 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent vulvovaginal candidiasis